Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,480 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Successful telaprevir treatment in combination of cyclosporine against recurrence of hepatitis C in the Japanese liver transplant patients.
Kikuchi M, Okuda Y, Ueda Y, Nishioka Y, Uesugi M, Hashimoto E, Takahashi T, Kawai T, Hashi S, Shinke H, Omura T, Yonezawa A, Ito T, Fujimoto Y, Kaido T, Chiba T, Uemoto S, Matsubara K, Masuda S. Kikuchi M, et al. Among authors: fujimoto y. Biol Pharm Bull. 2014;37(3):417-23. doi: 10.1248/bpb.b13-00769. Epub 2013 Dec 26. Biol Pharm Bull. 2014. PMID: 24369269 Free article.
Association between CYP3A5 genotypes in graft liver and increase in tacrolimus biotransformation from steroid treatment in living-donor liver transplant patients.
Hosohata K, Uesugi M, Hashi S, Hosokawa M, Inui K, Matsubara K, Ogawa K, Fujimoto Y, Kaido T, Uemoto S, Masuda S. Hosohata K, et al. Among authors: fujimoto y. Drug Metab Pharmacokinet. 2014;29(1):83-9. doi: 10.2133/dmpk.dmpk-13-rg-060. Epub 2013 Aug 13. Drug Metab Pharmacokinet. 2014. PMID: 23955548 Free article.
Influence of cytochrome P450 (CYP) 3A4*1G polymorphism on the pharmacokinetics of tacrolimus, probability of acute cellular rejection, and mRNA expression level of CYP3A5 rather than CYP3A4 in living-donor liver transplant patients.
Uesugi M, Hosokawa M, Shinke H, Hashimoto E, Takahashi T, Kawai T, Matsubara K, Ogawa K, Fujimoto Y, Okamoto S, Kaido T, Uemoto S, Masuda S. Uesugi M, et al. Among authors: fujimoto y. Biol Pharm Bull. 2013;36(11):1814-21. doi: 10.1248/bpb.b13-00509. Biol Pharm Bull. 2013. PMID: 24189425 Free article.
Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients.
Hashi S, Masuda S, Kikuchi M, Uesugi M, Yano I, Omura T, Yonezawa A, Fujimoto Y, Ogawa K, Kaido T, Uemoto S, Matsubara K. Hashi S, et al. Among authors: fujimoto y. Transplant Proc. 2014 Apr;46(3):758-60. doi: 10.1016/j.transproceed.2013.11.060. Transplant Proc. 2014. PMID: 24767342
Urinary neutrophil gelatinase-associated lipocalin: a useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients.
Tsuchimoto A, Shinke H, Uesugi M, Kikuchi M, Hashimoto E, Sato T, Ogura Y, Hata K, Fujimoto Y, Kaido T, Kishimoto J, Yanagita M, Matsubara K, Uemoto S, Masuda S. Tsuchimoto A, et al. Among authors: fujimoto y. PLoS One. 2014 Oct 20;9(10):e110527. doi: 10.1371/journal.pone.0110527. eCollection 2014. PLoS One. 2014. PMID: 25329716 Free PMC article. Clinical Trial.
2,480 results